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TREATMENT FIDELITY:  ITS IMPORTANCE AND REPORTED FREQUENCY IN 
APHASIA TREATMENT STUDIES 
 
ABSTRACT 
 
Treatment fidelity is a measure of the reliability of the administration of an intervention in a 
treatment study, and has important linkages and implications for the ultimate implementation of 
evidence-supported interventions.  In this study, we examined aphasia treatment studies 
published in the last 10 years for the reporting of treatment fidelity.  We found that only 10% of 
studies over the last 10 years reported treatment fidelity, which is less than other related 
disciplines.  We discuss the means by which we assess fidelity and recommend the consistent 
reporting of treatment fidelity in all treatment studies. 
 
STUDY DESCRIPTION 
 
Treatment fidelity refers to how well a treatment condition was implemented as planned in a 
research study (Vermilyea, Barlow, & O’Brien, 1984; Yeaton & Sechrest, 1981), and includes an 
assurance of reliability that the treatment conditions being compared are sufficiently different 
from each other (Moncher & Prins, 1991). 
 
Reported treatment fidelity is a critical component to the ultimate implementation of any 
evidence-supported intervention.  Firstly, we must be certain that a treatment that may ultimately 
become an evidence-based practice has been consistently administered throughout a clinical trial 
or treatment study, to ensure that the conclusions of the study are valid.  The phenomenon of 
“therapist drift” has been observed in which clinicians, even those who are participating in a 
treatment study, may make small but critical changes to the administration of a treatment in 
response to client performance.  This can be done unintentionally or even unknowingly, but may 
be part of a clinician’s expertise in matching client performance to treatment task. Thus, it is 
important to actively assess the reliability with which a studied treatment was administered in a 
study. When treatment integrity is not measured within a treatment study, results might 
be attributable to the planned treatment rather than the actually implemented 
treatment. Thus, reports of treatment integrity potentially affect the internal validity of a 
treatment study. 
 
Secondly, once a treatment is supported by evidence, practitioners will need to understand and be 
able to implement the critical components of the treatment in real settings.  A critical bridge 
between the accumulated evidence for a treatment and its implementation in real practice is an 
understanding of its critical components, which typically begins with the establishment of and 
the measure with which fidelity has been assessed (Fixsen, Naoom, Blasé, Friedman, & Wallace, 
2005; Frances, Sweeney, & Clarkson, 1985). This is critical for practitioners who may need to 
make adjustments to the administration of any particular treatment in order to accommodate 
client values, logistics, and institutional policies. 
 
Finally, as we envision the use of evidence-based practices in typical clinical settings, we will 
need fidelity measures with which quality assurance teams can determine how well and how 
effectively clinicians are administering a given evidence-based intervention. 
 In the last few years, a number of other disciplines have begun to self-examine their use of 
fidelity measures as practices from schools, health care, psychology, and medicine strive to 
implement evidence-based practices (Sanetti, Gritter, & Dobey, 2011;  
 
The purpose of this paper is to review published treatment studies in the journal 
Aphasiology for their inclusion of reported treatment integrity measures, and to discuss methods 
by which reported treatment fidelity can be improved. 
 
METHODS 
 
Studies published in Aphasiology from the last ten years (2002-2011) were reviewed. The 
following criteria were set for publication selection. Studies need to be an empirical study of an 
intervention administered across multiple sessions, and self-identified as a “treatment study”. 
Publications that were reviews of previously work, re-publications of older studies (e.g., 
“CAC Classics”), and retrospective studies were excluded. A total of 134 studies met these 
inclusion and exclusion criteria and were entered into the review. 
 
Each of these 134 studies was reviewed for identifying information, general description of the 
study design, dependent and independent variables, indication of whether any measure of 
treatment fidelity was explicitly included. The treatment description in each study was judged as 
to whether level of detail was sufficient for replication. 
 
The study design for each study was categorized based on groupings used by 
Gresham and colleagues (Gresham, Gansle, Noell, Cohen, & Rosenblum, 1993; see Table). 
Dependent and independent variables were listed in terms used by the study author(s). 
 
Studies were also coded as to whether the treatment description was operationally 
described at a level sufficient for replication. Raters were asked to consider “Could you 
replicate/implement this treatment based on the description in this publication?” If 
sufficient description was offered to allow for implementation, than “Yes” was coded. If 
the study was using a treatment for which there were additional published references or 
resources, then “Yes” was coded. 
 
Binary (yes/no) coding was also used to indicate whether studies reported any 
measure of treatment fidelity. Measures such as observations of treatment adherence, use 
of a training manual, or measures of procedural reliability were coded as “Yes”. For those 
studies that indicated treatment fidelity, additional details were recorded about how 
treatment integrity was established, sources used for treatment integrity, and how 
implementers of the treatment were trained. 
 
RESULTS 
 
The average number of treatment studies appearing in each of the five years was 12.8 studies 
appearing/year. Overall, the mean number of participants per 
study was 2 (range = 1-20 participants). 
 The majority of appearing studies incorporated a multiple baseline design, followed by other 
single subject designs. 
 
28% of the studies were judged to provide insufficient treatment description to allow for 
replication based on the publication alone. Some studies described fairly complex treatments that 
lacked detail; others described treatments that required clinician decision-making regarding tasks 
and trials, and criteria for these decisions were not offered. 
  
Thirteen of the 134 studies (10%) explicitly reported some aspect of treatment fidelity. 
The majority of these 13 studies checked adherence to steps in the treatment protocol by 
having one or more raters review videotapes from a sample (10-20%) of the training 
sessions, and asking the raters to indicate whether each step was observed. In these seven 
studies, a percentage of the treatment steps completed in the sampled sessions was 
reported. When more than one rater was used for checking protocol steps in sampled 
sessions, point-to-point agreement between the raters was reported. The Figure shows the total 
number of treatment studies per year with the number of studies reporting treatment fidelity. 
 
Two of these studies that reported treatment fidelity described the use of a training manual. In 
one other study, implementers were trained prior to initiation of the treatment study via role 
playing (Melton & Bourgeois, 2005). So, three of the reviewed studies explicitly mentioned how 
implementers of the treatment were themselves trained. One study (Hickey, Bourgeois, & 
Olswang, 2004) reported both a training manual and independent ratings of training adherence. 
 
DISCUSSION 
 
The purpose of this review was to describe the reporting of treatment fidelity 
among treatment studies published in Aphasiology in the last ten years. Of 134 reviewed 
studies, approximately 10% reported some measure of treatment fidelity. The primary method 
used in these studies was review of video samples of treatment sessions for evaluation of 
adherence to treatment protocol steps. 
 
The percentage of studies reporting measures of treatment integrity in this review 
was similar to reviews of treatment integrity in the school-based intervention literature 
(Peterson, Homer, & Wonderlich, 1982; Gresham, Gansle, Noell, Cohen, & Rosenblum, 
1993) but generally less that more recent evaluations of reported treatment fidelity in other 
disciplines (McEvoy, Shores, Wehby, Johnson, & Fox, J J., 1990; Sanetti, Gritter, & Dobey, 
2011).  Furthermore, some areas in speech-language pathology are paying particular attention to 
this issue (Wheeler, Baggett, Fox, & Blevins, 2006; Schlosser, 2002). 
 
Additional discussion will focus on methods of conducting treatment integrity. Attending to 
treatment integrity in our single studies will make our conclusion more reliable and robust and 
set the stage for the implementation of evidence-based practice. 
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Table. Study design coding categories used in the review (from Gresham, 
Gansle, Noell, Cohen, & Rosenblum, 1993). 
 
Group = use of an experimental group and a control group or a comparison of two or 
more treatment groups 
 
Withdrawal designs = comparisons within subject designs in which changes are 
compared across phases of the study (e.g., A/B/A/B, etc.) 
 
Multiple Baseline designs = Comparisons of both within and between subjects and/or 
behaviors 
 
Alternating Treatments = Alternating treatment components across sessions or days 
 
Changing Criterion designs = Within series change strategies in which the dependent 
variables is brought under the control of established and shifting criteria 
 
 
Figure. The total number of aphasia treatment studies published each year with the number of 
those studies reporting treatment fidelity measures. 
 
 
